Ellagic acid inhibits growth and arylamine N-acetyltransferase activity and gene expression in Staphylococcus aureus

In Vivo

Volumn 19, Issue 1, 2005, Pages 195-200

  Lu, Hsu Feng ^a   Tsou, Mei Fen ^b   Lin, Jaung Gung ^c   Ho, Chin Chin ^d   Liu, Jia You ^a   Chuang, Jing Yuan ^c   Chung, Jing Gung ^c  

^a CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

Author keywords

2 aminofluorene (AF); Ellagic acid; N acetyl 2 aminofluorene (AAF); N acetyltransferase; S. aureus

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; ELLAGIC ACID; MESSENGER RNA;

ACETYLATION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; ENZYME KINETICS; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS;

EID: 16244395488     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Weber WW and Hein DW: N-acetylation pharmacogenetics. Pharmacol Rev 37: 25-79, 1985.
2. Hein DW, Omichinski JG, Brewer JA and Weber WW: A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J Pharm Exp Ther 220: 8-15, 1982.
3. Hein DW, Rustan JD, Bucher KD, Furman EJ and Martin WJ: Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor targets organs of an inbred rat models. J Pharmacol Exp Ther 258: 232-236, 1991.
4. Das M, Bickers DR and Mukhtar H: Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. Carcinogenesis 6: 1409-1413, 1985.
5. Ahn D, Putt D, Kresty L, Stoner GD, Fromm D and Hollenberg PF: The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes p450 and phase II enzymes. Carcinogenesis 17: 821-828, 1996.
6. Chung JG: Inhibitory actions of ellagic acid on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Microbios 93: 115-127, 1998.
7. Lin SS, Hung CF, Tyan YS, Yang CC, Hsia TC, Yang MD and Chung JD: Ellagic acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301). Urol Res 29: 371-376, 2001.
8. Teel RW: Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Cancer Lett 30: 329-336, 1986.
9. Thresiamma KC and Kuttan R: Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol 40: 363-366, 1996.
10. Narayanan BA, Geoffroy O, Willingham MC, Re GG and Nixon DW: P53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136: 215-221, 1999.
11. Narayanan BA and Re GG: IGF-II down-regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res 21: 359-364, 2001.
12. Li YC, Tyan YS, Kuo HM, Chang WC, Hsia TC and Chung JG: Baicalein induced in vitro apoptosis undergo caspases activity in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 42: 37-43, 2004.
13. Ormerod MG: In: Flow Cytometry: A Practical Approach, pp. 69-81. Oxford University Press, New York, 1990.
14. Chung JG, Yeh KT, Wu SL, Chen GW, Hsu NY and Ho HC: Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display. Cancer Res 61: 8873-8879, 2001.
15. Chang BD, Swift ME, Shen M, Fang J, Broude EV and Roninson IB: Molecular determinants of terminal growth arrest induced in tumor cells by chemotherapeutic agent. Proc Natl Acad Sci USA 99: 389-394, 2002.
16. Lo HH and Chung JG: The effects of plant phenolics, caffeic acid, chlorogenic acid and ferulic acid on arylamine N-acetyltransferase activities in human gastrointestinal microflora. Anticancer Res 19: 133-140, 1999.
17. Chung JG: Inhibitory actions of ellagic acid on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Microbios 93: 115-27, 1998.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem 72: 248-254, 1976.
19. Hsia TC, Chung JG, Lu HF, Ho HC, Yang CC, Lu KH and Hung CF: The effect of paclitaxel on 2-aminofluorene-DNA adducts formation and arylamine N-acetyltransferase activity and gene expression in human lung tumor cells (A549). Food Chem Toxicol 40: 697-703, 2002.
20. Cleland WW: The statistical analysis of enzyme kinetics data. Adv Enzymol 29: 1-32, 1967.
21. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi T, Ilett KF and Kadlubar FF: N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem Biophys Res Commun 185: 839-844, 1992.
22. Grant DM, Blum M, Beer M and Meyer UA: Monomorphic and polymorphic human arylamine N-acetyltransferase: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39 184-191, 1991.
23. Larse GL: Deconjugation of biliary metabolites by microfloral β-glucuronidase, sulphatase and cysteine conjugate β-lyase and their subsequent enterohepatic circulation. In. Rowland I (ed.), Role of Gut Flora in Toxicity and Cancer, pp 79-107 London: Academic Press, 1988.
24. Kinouchi T, Kataoka K, Miyanishi K, Akimoto S and Ohnishi Y: Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administrated glutathione conjugates of K-region epoxides of 1-nitropyrene. Carcinogenesis (Lond.) 14: 869-874, 1993.
25. Okumuro F, Uedo O, Kitamuru S and Tatsumi K: N-acetylation and N-formation of carcinogenic arylamines and related compounds in dogs. Carcinogenesis 1: 71-76, 1995.
26. Zubay GL, Parson WW and Vance DE: Principles of Biochemistry. pp.135-153. Wm. C. Brown Publishers, 1955.
27. Kinouchi T, Kataoka K, Miyanishi K, Akimoto S and Ohnishi Y: Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administrated glutathione conjugates of K-region epoxides of 1-nitropyrene. Carcinogenesis (Lond.) 14: 869-874, 1993.